OPTN | OptiNose, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.3211 - 0.4625
52 Week Range	0.3211 - 2.1000
Beta	-0.09
Implied Volatility	271.82%
IV Rank	64.36%
Day's Volume	1,301,771
Average Volume	505,850
Shares Outstanding	150,830,000
Market Cap	55,354,610
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2017-10-13

Valuation
Profitability
Growth
Health
P/E Ratio	-1.27
Forward P/E Ratio	-4.53
EPS	-0.29
1YR Price Target	8.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	132
Country	USA
Website	OPTN

OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.

OPTN's peers: COLL, PAHC, ANIP, PROC, SSIC, LFCR, KMDA, SHPH, CPIX, IRWD, AMPH, EGRX, ALKS, EOLS, PBH, RGC, NBIX, ITCI, DCPH, DVAX

*Chart delayed

Analyzing fundamentals for OPTN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is good and Health is very weak. For more detailed analysis please see OPTN Fundamentals page.

Watching at OPTN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on OPTN Technicals page.